GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Amoy Diagnostics Co Ltd (SZSE:300685) » Definitions » Price-to-Owner-Earnings

Amoy Diagnostics Co (SZSE:300685) Price-to-Owner-Earnings : 34.50 (As of May. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Amoy Diagnostics Co Price-to-Owner-Earnings?

As of today (2024-05-24), Amoy Diagnostics Co's share price is ¥18.63. Amoy Diagnostics Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥0.54. It's Price-to-Owner-Earnings for today is 34.50.


The historical rank and industry rank for Amoy Diagnostics Co's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:300685' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 30.94   Med: 59.17   Max: 235.66
Current: 34.36

During the past 12 years, the highest Price-to-Owner-Earnings of Amoy Diagnostics Co was 235.66. The lowest was 30.94. And the median was 59.17.


SZSE:300685's Price-to-Owner-Earnings is ranked worse than
65.67% of 67 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.81 vs SZSE:300685: 34.36

As of today (2024-05-24), Amoy Diagnostics Co's share price is ¥18.63. Amoy Diagnostics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.68. Therefore, Amoy Diagnostics Co's PE Ratio for today is 27.40.

As of today (2024-05-24), Amoy Diagnostics Co's share price is ¥18.63. Amoy Diagnostics Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.69. Therefore, Amoy Diagnostics Co's PE Ratio without NRI for today is 26.84.

During the past 12 years, Amoy Diagnostics Co's highest PE Ratio without NRI was 105.64. The lowest was 18.83. And the median was 60.42.


Amoy Diagnostics Co Price-to-Owner-Earnings Historical Data

The historical data trend for Amoy Diagnostics Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoy Diagnostics Co Price-to-Owner-Earnings Chart

Amoy Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.24 118.13 80.98 45.21 41.47

Amoy Diagnostics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.30 36.93 59.03 41.47 40.20

Competitive Comparison of Amoy Diagnostics Co's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Amoy Diagnostics Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amoy Diagnostics Co's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Amoy Diagnostics Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Amoy Diagnostics Co's Price-to-Owner-Earnings falls into.



Amoy Diagnostics Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Amoy Diagnostics Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=18.63/0.54
=34.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amoy Diagnostics Co  (SZSE:300685) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Amoy Diagnostics Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Amoy Diagnostics Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Amoy Diagnostics Co (SZSE:300685) Business Description

Traded in Other Exchanges
N/A
Address
39 Dingshan Road, Haicang District, Xiamen, CHN, 361027
Amoy Diagnostics Co Ltd is the pharmaceutical company based in China. The company primarily focuses on molecular diagnostics for oncology precision medicine. It provides diagnostic products and services for medicine development and clinical oncology practice. The company's products include gene mutation, nucleic acid extraction, and molecular diagnostic kits comprising EGFR, RAS, ALK, BRAF, PIK3CA, and ROS1 testing kits.

Amoy Diagnostics Co (SZSE:300685) Headlines

No Headlines